A phase II study of temozolomide, thalidomide, and lomustine in the treatment of advanced melanoma
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Lomustine; Temozolomide; Thalidomide
- Indications Malignant melanoma
- Focus Therapeutic Use
- 18 Jan 2013 Biomarkers information updated
- 22 Dec 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 16 Sep 2005 New trial record.